Welcome to our dedicated page for Unusual Machines SEC filings (Ticker: UMAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Unusual Machines, Inc. (UMAC) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Unusual Machines is a Nevada corporation with common stock listed on NYSE American under the symbol UMAC, and it files current and periodic reports that describe its operations, governance, and financial position.
Among the most relevant documents for investors are the company’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which present audited or reviewed financial statements, segment information, and management’s discussion of results. For example, a shareholder letter furnished with a Form 8‑K references a Form 10‑Q filing and provides context on revenue trends, margins, cash position, and capital raises, all of which are detailed in the underlying report.
Unusual Machines also files numerous Current Reports on Form 8-K that disclose material events. Recent 8‑Ks describe items such as purchase orders from Performance Drone Works, a strategic supplier agreement with Dynamic Aerospace Systems, an adjournment and subsequent results of the 2025 Annual Meeting of Stockholders, the lease of a 25,000-square-foot Orlando facility for manufacturing and fulfillment, and a $25 million investment into XTI Aerospace via Series 10 Convertible Preferred Stock. Other 8‑Ks furnish investor presentations and shareholder letters, giving additional insight into strategy and operations.
Proxy materials, including the Definitive Proxy Statement on Schedule 14A, outline board elections, annual meeting procedures, and governance matters. These documents detail how directors are chosen, how stockholders can vote (including virtual meeting logistics), and what proposals are on the ballot.
On Stock Titan, Unusual Machines filings are updated in near real time from EDGAR, and AI-powered summaries help explain the key points of lengthy reports such as 10‑K and 10‑Q filings. Users can quickly understand topics like capital structure changes, lease commitments for new facilities, strategic investments, and outcomes of shareholder votes without reading every page. The filings page also makes it easier to monitor Form 4 insider transaction reports and other ownership-related filings when they are available, giving a clearer view of how executives and major holders interact with UMAC stock.
By using this page, investors can efficiently review Unusual Machines’ regulatory history, from financial performance and manufacturing expansion to governance decisions and strategic partnerships, with AI tools that highlight the most important disclosures in each filing.
Unusual Machines, Inc. completed the acquisition of 100% of the capital stock of Australian company Rotor Lab Pty Ltd on September 3, 2025. The sellers, Andrew Robert Simpson and Vella Hardjadinata Corporation Pty Ltd as trustee for Vella Hardjadinata Family Trust, received 656,642 shares of Unusual Machines common stock as initial consideration, with potential additional earnout consideration of up to
Of the initial consideration, 131,328 shares will be subject to possible forfeiture for one year after closing in the event of specified breaches and indemnification claims. The shares were issued under the company’s effective shelf registration statement on Form S-3 and a related prospectus supplement. Rotor Lab will operate as a wholly owned subsidiary serving as an engineering hub for motor design and prototyping, and the sellers have agreed to two-year non-compete periods following closing.
Unusual Machines, Inc. filed a prospectus supplement on Form 424B5 for resale of 656,642 shares of common stock by selling stockholders, increasing pro forma common shares to 31,105,199. The company will not receive proceeds from this resale offering. The prospectus supplement references substantial risk factors including potential manufacturing equipment defects, cost overruns on fixed-price orders, challenges establishing a drone motor manufacturing facility, supply chain and inventory management risks, cybersecurity and regulatory risks, and possible dilution from prior and future equity issuances. Pro forma adjustments also reflect a July 15, 2025 registered direct offering of 5,000,000 shares for net proceeds of approximately $44.9 million and additional equity grants and option exercise potential.
Unusual Machines, Inc. entered into a Capital on Demand™ Sales Agreement with JonesTrading Institutional Services LLC, allowing it to issue and sell over time up to $300,000,000 of common stock through an at-the-market offering program. Shares may be sold on the NYSE American or other U.S. trading markets, to or through dealers, or directly to JonesTrading as principal using methods permitted by law. JonesTrading will use commercially reasonable efforts to sell the requested shares and will receive a 3.0% commission on gross proceeds from any sales.
The company will also reimburse JonesTrading up to $55,000 for initial counsel fees and up to $3,750 per quarter for ongoing due diligence legal updates. The shares are being offered under an effective Form S-3 shelf registration statement and a related prospectus supplement filed with the SEC, which together govern the detailed terms and disclosures for this at-the-market equity program.
Unusual Machines, Inc. (UMAC) is offering up to $300,000,000 of Common Stock, which at an assumed price of $10.25 per share would equal up to 29,268,293 shares. The prospectus lists 30,448,557 shares currently outstanding and states an illustrative post-offering outstanding share count of 59,774,071 (using $10.23 per share). Net tangible book value was $1.64 per share as of June 30, 2025. Proceeds are intended for working capital and general corporate purposes, though management retains broad discretion over their use. The supplement cross-references a multi-page Risk Factors section and details potential operational risks including manufacturing equipment defects, cost overruns on fixed-price orders, staffing and reporting challenges at the recently acquired Rotor Lab (including 656,642 shares issued as initial consideration), supply chain and inventory risks, competitive pressures, intellectual property risks, macroeconomic and cybersecurity risks. Specific offering mechanics, securities descriptions and plan-of-distribution methods are available in the prospectus supplement and incorporated documents.
Unusual Machines, Inc. filed a current report to let investors know it has released a new shareholder communication. On August 27, 2025, the company issued a press release that includes a Letter to Shareholders, which is provided as Exhibit 99.1 to this report.
The company clarifies that this shareholder letter and related press release are being furnished rather than filed under securities laws, meaning they are not subject to certain liability provisions and are not automatically incorporated into other Unusual Machines filings. The report is signed by Chief Executive Officer Allan Evans on behalf of the company.
Andrew Camden, Chief Operating Officer of Unusual Machines, Inc. (UMAC), reported two planned sales of common stock under a Rule 10b5-1 plan to cover tax obligations from prior equity grants. On 08/20/2025 he sold 8,750 shares at a weighted-average price of $9.8005, reducing his direct ownership to 224,750 shares. On 08/21/2025 he sold 35,000 shares at a weighted-average price of $10.2075, reducing his direct ownership to 189,750 shares. The filer states the sales were executed by an independent third party and the original grants were exempt from Section 16(b) under Rule 16b-3. The filing is signed and dated 08/22/2025.
Brian Joseph Hoff, Chief Financial Officer of Unusual Machines, Inc. (UMAC), reported two open-market sales under a Rule 10b5-1 plan. On 08/20/2025 he sold 8,750 shares at a weighted average price of $9.8005, leaving him with 407,975 shares. On 08/21/2025 he sold 33,750 shares at a weighted average price of $10.2075, leaving him with 374,225 shares. The filings state the sales were to cover income taxes from prior equity grants and were executed by an independent third party under the 10b5-1 plan. The report is signed by Mr. Hoff on 08/22/2025.
Rich Sanford, a director of Unusual Machines, Inc. (UMAC), acquired 2,308 shares of the issuer's restricted common stock on 08/19/2025 at a $0 price. After the grant, Sanford beneficially owned 150,242 shares. The restricted shares are fully vested, subject to the company's standard Restricted Stock Agreement, were granted under the Issuer's 2022 Equity Incentive Plan, and the grant was approved by the Board of Directors, making it exempt from Section 16(b) under Rule 16b-3.
The Form 4 was signed by Sanford on 08/21/2025 and filed as an individual reporting person. No derivative transactions or cash-paid purchases are reported in this filing.
Director Cristina Colon received a grant of 2,308 shares of restricted common stock of Unusual Machines, Inc. (UMAC) on 08/19/2025. The shares were issued at a price of $0 and are reported as fully vested following execution of the company's standard Restricted Stock Agreement. After the grant, Ms. Colon beneficially owns 60,980 shares. The grant was approved by the board and stated as exempt from Section 16(b) under Rule 16b-3, and was made under the Issuer's 2022 Equity Incentive Plan, as amended.
Insider grant and resulting holdings: Director Jeffrey M. Thompson received a grant of 2,308 shares of restricted common stock of Unusual Machines, Inc. (UMAC) on 08/19/2025. The shares were granted under the issuer's 2022 Equity Incentive Plan, are fully vested, and are subject to the company’s standard Restricted Stock Agreement. The grant was approved by the Board and exempt from Section 16(b) under Rule 16b-3. Following the grant, Thompson beneficially owns 337,460 shares. The Form 4 was signed on 08/21/2025.